Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Industry Chafes At Kennedy Bill’s Council For Qualifying Insurance Plans

This article was originally published in The Gray Sheet

Executive Summary

Device industry lobbyists worry that a section in Sen. Ted Kennedy's comprehensive health reform bill could give government too much power to restrict coverage of medical products based on cost. They are seeking clarifying language

You may also be interested in...



AdvaMed Critical Of House Approach To Setting Minimum Benefits Package

A provision in the recently passed House health care reform bill designed to define qualifying requirements for a health plan to be included in a new national insurance exchange would give too much power to the government over use of devices, industry reps say

AdvaMed Critical Of House Approach To Setting Minimum Benefits Package

A provision in the recently passed House health care reform bill designed to define qualifying requirements for a health plan to be included in a new national insurance exchange would give too much power to the government over use of devices, industry reps say

Health Reform Roundup: A Week Of Ups And Downs For Democratic Effort

Three of the five involved committees in Congress approved comprehensive health care reform legislation last week, but it was still a week laden with barriers and delays to the overall goal of getting legislation to the president's desk

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT027547

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel